Royce & Associates’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.58M Buy
888,030
+206,000
+30% +$1.91M 0.06% 447
2025
Q4
$8.36M Buy
682,030
+4,700
+0.7% +$76.8K 0.08% 363
2025
Q3
$13.9M Sell
677,330
-113,310
-14% -$1.8M 0.14% 227
2025
Q2
$10.7M Sell
790,640
-203,660
-20% -$2.23M 0.11% 273
2025
Q1
$8.61M Sell
994,300
-75,260
-7% -$460K 0.09% 322
2024
Q4
$5.2M Buy
+1,069,560
New +$5.98M 0.05% 469
2022
Q3
Sell
-44,000
Closed -$1.21M 960
2022
Q2
$1.21M Hold
44,000
0.01% 729
2022
Q1
$1.66M Buy
+44,000
New +$1.95M 0.01% 745
2021
Q4
Sell
-11,450
Closed -$980K 1006
2021
Q3
$980K Sell
11,450
-13,750
-55% -$863K 0.01% 821
2021
Q2
$1.56M Buy
25,200
+800
+3% +$40.7K 0.01% 794
2021
Q1
$1.19M Buy
24,400
+1,500
+7% +$72.4K 0.01% 832
2020
Q4
$714K Buy
22,900
+2,900
+15% +$71K 0.01% 850
2020
Q3
$417K Buy
20,000
+5,100
+34% +$87.6K ﹤0.01% 877
2020
Q2
$194K Buy
+14,900
New +$162K ﹤0.01% 936

Other funds holding OPRX